Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
135.41
+0.61 (+0.46%)
Streaming Delayed Price
Updated: 10:35 AM EDT, May 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
44
45
Next >
Earnings Scheduled For April 17, 2024
April 17, 2024
Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is projected to report quarterly earnings at $3.43 per share on revenue of $6.13 billion.
Via
Benzinga
Investor Optimism Decreases; Dow Ends 6-Session Losing Streak
April 17, 2024
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index remaining in the "Fear" zone on Tuesday. U.S. stocks closed mixed on Tuesday amid increased...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
April 17, 2024
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Abbott Laboratories Dividend Stock Analysis
April 12, 2024
Abbott Laboratories discovers, develops, manufactures, and sells healthcare products. Its products include branded generic pharmaceuticals manufactured internationally, marketed, and sold outside the...
Via
Talk Markets
Abbott Laboratories Unusual Options Activity
April 11, 2024
Via
Benzinga
Analyst Ratings For Abbott Laboratories
April 03, 2024
Via
Benzinga
Johnson & Johnson is as Cheap as it’s Going to Get
April 16, 2024
Johnson & Johnson raised its dividend for the 62nd consecutive year and has the power to continue raising the annual payout indefinitely.
Via
MarketBeat
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
April 16, 2024
Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28.
Via
Talk Markets
3 Buy Rated Stocks To Consider As Earnings Approach
April 13, 2024
With the Q1 earnings season underway, there will be a microscope on companies that can continue to show improvements in their outlook amid an uptick in inflation.
Via
Talk Markets
Jim Cramer Calls Cummins 'Terrific,' Recommends Selling This Chinese Auto Manufacturer
April 12, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes New Fortress Energy Inc.
Via
Benzinga
How Is The Market Feeling About Abbott Laboratories?
March 28, 2024
Via
Benzinga
Performance Comparison: Abbott Laboratories And Competitors In Health Care Equipment & Supplies Industry
March 27, 2024
Via
Benzinga
What the Options Market Tells Us About Abbott Laboratories
March 19, 2024
Via
Benzinga
Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit
April 12, 2024
Continuous glucose monitors have spiked in popularity since the advent of weight-loss drugs. Is chronic disease at its end?
Via
Investor's Business Daily
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
April 11, 2024
These companies provide stability, reliability, and passive income.
Via
The Motley Fool
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
April 10, 2024
Although the market may be grumbling over certain issues, concerned investors can trust these healthcare stocks to deliver the goods.
Via
InvestorPlace
Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'
April 09, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over
Via
Benzinga
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
April 09, 2024
Income-seeking investors can look forward to steady payout raises from these pharma stocks.
Via
The Motley Fool
3 Top Dividend Stocks to Buy in April 2024
April 06, 2024
Each of these high-quality stocks looks like a buy.
Via
The Motley Fool
Top Analyst Reports For T-Mobile US, Abbott Laboratories & Palo Alto Networks
April 06, 2024
Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Palo Alto Networks, Inc. (PANW).
Via
Talk Markets
FDA Approves Abbott's Heart Valve Repair Device For Patients At Risk Of Complications/Death During Open-Heart Surgeries
April 02, 2024
FDA approves Abbott Laboratories' TriClip TEER system for treating tricuspid regurgitation. Clip technology offers non-invasive repair, fast recovery, and significant improvement in quality of life....
Via
Benzinga
Exposures
Product Safety
DexCom Stock Gains from GLP-1 Diabetic Users
April 02, 2024
DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People
Via
MarketBeat
Russell 2000 Index Best And Worst Performing Stocks Of 2024
April 02, 2024
The Russell 2000 index continued to underperform the Dow Jones and Nasdaq 100 indices in the first quarter of 2024.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
3 Strong Buy Healthcare Stocks to Add to Your Q2 Must-Watch List
March 29, 2024
In an aging world, strong buy healthcare stocks like UNH, ABT, and MRK shine with dividends, innovation, and market growth.
Via
InvestorPlace
Winning Over Wall Street: 3 Stocks Earning Overwhelming Analyst Approval
March 26, 2024
Discover the investment potential of three stocks with analyst approval for their robust financials and strategic market positions.
Via
InvestorPlace
More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’
March 25, 2024
Investors should take notice of these stocks with high analyst ratings. It's time to load up your portfolio.
Via
InvestorPlace
Want Decades of Passive Income? 2 Stocks to Buy Now.
March 22, 2024
There aren't many guarantees in the equity market, but the dividend payouts of Johnson & Johnson and Abbott Laboratories may be as close as it gets to a sure thing.
Via
The Motley Fool
3 Stocks to Buy Right Now for the Coming Recession
March 21, 2024
With numerous economic indicators souring, these three stocks to buy for a recession will protect your portfolio's downside.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
3 Resilient Stocks to Protect Your Wealth During a Recession
March 21, 2024
Discover three recession-resistant stocks with growth leads in the consumer staples, household products, and healthcare industries.
Via
InvestorPlace
Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)
March 20, 2024
Via
AB Newswire
Topics
Death
Exposures
Death
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
44
45
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.